Clinical Trial Update: L-Arginine, Vascular Response and Mechanisms [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the effect of L-Arginine on vascular response and mechanisms in hypertension and diabetes. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypertension

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Hypertension, Diabetes | Phase 2 | Status: COMPLETED